Decrease of free thyroxine levels after controlled ovarian hyperstimulation by Muller, A.F. (Alex) et al.
Decrease of Free Thyroxine Levels after Controlled
Ovarian Hyperstimulation*
A. F. MULLER, A. VERHOEFF, M. J. MANTEL, F. H. DE JONG, AND A. BERGHOUT
Departments of Internal Medicine (A.F.M., A.B.), Obstetrics and Gynecology (A.V.), and Clinical
Chemistry (M.J.M.), Zuiderziekenhuis Rotterdam, 3075 EA Rotterdam, The Netherlands; and
Department of Internal Medicine III, University Hospital Dijkzigt (F.H.d.J.), 3015 GD Rotterdam,
The Netherlands
ABSTRACT
Controlled ovarian hyperstimulation could lead to opposing effects on
thyroid function. Therefore, in a prospective study of 65 women under-
going controlled ovarian hyperstimulation, thyroid hormones, T4-bind-
ing globulin, TPO antibodies, gonadotropins, estradiol, and PRL were
measured before and after controlled ovarian hyperstimulation.
After ovarian stimulation (mean 6 SE of mean): free T4 de-
creased, 14.4 6 0.2 vs. 12.9 6 0.2 pmol/L (P , 0.0001); thyroid-
stimulating hormone increased, 2.3 6 0.3 vs. 3.0 6 0.4 mU/L (P ,
0.0001); T4-binding globulin increased, 25.2 6 0.7 vs. 33.9 6 0.9
mg/L (P , 0.0001); total T4 increased, 98.1 6 2.3 vs. 114.6 6 2.5
nmol/L (P , 0.0001); total T3 increased, 2.0 6 0.04 vs. 2.3 6 0.07
nmol/L (P , 0.0001); TPO antibodies decreased, 370 6 233 U/mL
vs. 355 6 224 U/mL (P , 0.0001); LH decreased, 8.1 6 1.1 vs. 0.4 6
0.1 U/L (P , 0.0001); FSH did not change, 6.5 6 0.6 vs. 7.9 6 0.9
U/L (P 5 0.08); human CG increased, ,2 6 0.0 vs. 195 6 16 U/L
(P , 0.0001); estradiol increased, 359.3 6 25.9 pmol/L vs. 3491.8 6
298.3 pmol/L (P , 0.0001); and PRL increased, 0.23 6 0.02 vs.
0.95 6 0.06 U/L (P , 0.0001).
Because low maternal free T4 and elevated maternal thyroid-stim-
ulating hormone levels during early gestation have been reported to
be associated with impaired psychomotor development in the off-
spring, our findings indicate the need for additional studies in the
children of women who where exposed to high levels of estrogens
around the time of conception. (J Clin Endocrinol Metab 85: 545–548,
2000)
LOW MATERNAL free T4 (fT4) levels during early ges-tation are associated with impaired psychomotor de-
velopment in infancy, persisting into childhood (1, 2).
During pregnancy, high estradiol (E2) levels lead, through a
rise in T4-binding globulin (TBG), to a transient drop in fT4
levels (3–5). Human CG (hCG) is known to exert a thyrotrophic
action both in vitro and in vivo, best explained by the structural
homology of thyroid-stimulating hormone (TSH) and hCG and
their respective receptors (6). This explains why serum TSH
does not rise during the first trimester but decreases reciprocally
with the increase in hCG (5). Controlled ovarian hyperstimu-
lation—for conventional in vitro fertilization (IVF) or intracy-
toplasmic sperm injection (ICSI)—could, therefore, lead to op-
posing effects on thyroid function: the thyrotrophic action of
hCG could result in elevated fT4 levels; alternatively, the in-
duced rise in E2 could lead to a lowering of fT4.
The aim of the present study was to determine the acute
effects of controlled ovarian hyperstimulation on thyroid
function. We, therefore, designed a prospective study of
women undergoing controlled ovarian hyperstimulation.
Materials and Methods
We studied 65 of 177 women who previously participated in a pro-
spective study on thyroid autoimmunity and abortion (7). The study was
approved by the hospital ethics committee, and all subjects gave in-
formed consent at initial presentation.
Our IVF program has been described in detail previously (8). Ovarian
stimulation consisted of a 1-mg GnRH-analog sc or intranasally from
cycle day 1 to days 10–12, 225 IU human menopausal gonadotrophin
(hMG) im from day 3 to days 9–11, and 10,000 IU hCG im 35 h before
follicle puncture. Follicle growth was assessed by ultrasound from day
10. Follicle puncture was done on day 14 in the majority of women. There
was no difference in controlled ovarian hyperstimulation in those re-
ceiving ICSI and conventional IVF. Blood was drawn at random during
the menstrual cycle from all women at their initial visit and after ovu-
lation induction immediately before or after transvaginal follicle punc-
ture. After the initial visit, TSH was determined immediately, whereas
all other assays were done from frozen samples (270 C).
To investigate assay cross-reactivity, one ampoule hMG (75,000 U/L)
was diluted in saline to 75 U/L. In this solution TSH and hCG were
measured.
Assays
TSH, total T3, fT4, FSH, LH, hCG (total and b), and PRL were de-
termined with an immunoluminometric assay (Chiron Corp., East Wal-
pole, MA). Reference ranges were: TSH, 0.2–4.5 mU/L; total T3, 1.3–2.8
nmol/L; fT4, 9–22 pmol/L; and PRL, 0.03–0.63 U/L. Total T4 was de-
termined with a in-house RIA with a reference range of 64–132 nmol/L.
TBG was determined with a RIA (Brahms, Berlin, Germany). Estradiol
was determined with a RIA (Diagnostic Product Corporation, Los An-
geles, CA). TPO antibodies were determined with a RIA (Henning Berlin
GmbH & Co., Berlin, Germany).
Statistics
Qualitative data between groups were tested using the x2 test. Data
on hormones and antibodies were analyzed by the Wilcoxon matched-
pairs signed-ranks test; correlations are given as Spearman’s rank cor-
relation coefficient (all P values are two-sided). P values of less than 0.05
were considered significant. Data are presented as mean 6 se of mean.
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Results
General data
There were no differences in age, cause of infertility, thy-
roid function, family history of thyroid disease, smoking
behavior (Table 1), number of previous pregnancies and
deliveries or spontaneous abortions between study subjects
and those who did not consent to repeated blood sampling
(nonparticipants). None of the study subjects used thyroid
medication.
Thyroid function and TPO antibodies
After ovarian stimulation: fT4 decreased, (before vs. after)
14.4 6 0.2 pmol/L vs. 12.9 6 0.2 pmol/L (P , 0.0001) (Fig.
1); total T4 increased, 98.1 6 2.3 nmol/L vs. 114.6 6 2.5
nmol/L (P , 0.0001); total T3 increased, 2.0 6 0.05 nmol/L
vs. 2.3 6 0.07 nmol/L (P , 0.0001); TBG increased, 25.2 6 0.7
mg/L vs. 33.9 6 0.9 mg/L (P , 0.0001); TSH increased, 2.3 6
0.3 mU/L vs. 3.0 6 0.4 mU/L (P , 0.0001) (Fig. 2); and TPO
antibodies decreased, 370 6 233 U/mL vs. 355 6 224 U/mL
(median, 57 U/mL and 44 U/mL, respectively) (P , 0.0001).
In those women receiving ICSI, fT4 was slightly, but sig-
nificantly, higher after ovarian hyperstimulation compared
with women receiving conventional IVF: 13.7 6 0.4 pmol/L
vs. 12.6 6 0.3 pmol/L (P , 0.05).
Gonadotropins, E2, and PRL
After ovarian stimulation: LH decreased, 8.1 6 1.1 U/L vs.
0.4 6 0.1 U/L (P , 0.0001); FSH did not change, 6.5 6 0.6 U/L
vs. 7.9 6 0.9 U/L (P 5 0.08); E2 increased, 359.3 6 25.9
pmol/L vs. 3491.8 6 298.3 pmol/L (P , 0.0001); hCG in-
creased, less than 2 6 0.0 U/L vs. 195 6 16 U/L (P , 0.0001);
and PRL increased: 0.23 6 0.02 U/L vs. 0.95 6 0.06 U/L (P ,
0.0001).
Correlations
A significant correlation exists between the increase in E2
and the increase in TBG (Fig. 3) and total T4; r 5 0.50, P ,
0.0001 and r 5 0.73, P , 0.0001, respectively. The increase in
TBG was significantly correlated with the decrease in fT4; r 5
20.26, P , 0.05 (Fig. 4).
Assay cross-reactivity
In the saline containing 75 U/L FSH and LH (hMG), TSH
and hCG levels were, respectively, 0.02 mU/L and 12 U/L,
indicating that the gonadotropins did not contribute signif-
icantly to the levels of TSH and hCG estimated after ovula-
tion induction.
Discussion
In this prospective study, we found controlled ovarian
hyperstimulation to lead to a lowering of fT4 levels concom-
FIG. 1. fT4 levels before and after ovarian stimulation.
TABLE 1. General data
Variable Study subjects(n 5 65)
Nonparticipants
(n 5 112) P value
Mean (6SEM) TSH level (mU/L)a 2.3 6 0.3 1.8 6 0.1 NS
Median TSH level (mU/L)a 1.65 1.65 NS
No. of patients (%) with indicated TSH level
,0.20 2 (3) 4 (4) NS
$0.2–#4.5 59 (91) 102 (91) NS
.4.5 4 (6) 4 (4) NS
Mean (6SD) age (yr) 32.7 6 4.0 32.1 6 4.4 NS
No. of patients with indicated cause of infertility (%)b
Male infertility or fallopian tube obstruction 44 (68) 72 (64) NS
Endometriosis 4 (6) 7 (6) NS
PCOS 4 (6) 7 (6) NS
Idiopathic 13 (20) 24 (21) NS
No. of patients with a family history of thyroid disease (%)c 7 (11) 13 (12) NS
No. of patients who smoke (%)d 16 (25) 44 (39) NS
No. of patients who underwent conventional IVF 49 (75) 77 (69) NS
No. of patients who underwent ICSI 16 (25) 35 (31) NS
PCOS, Polycystic ovary syndrome.
a TSH level not determined in two nonparticipants.
b Cause of infertility unknown in two nonparticipants.
c Family history of thyroid disease unknown in two nonparticipants.
d Smoking behavior unknown in three women, one of whom was a participant.
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itant with a rise in TSH, indicating decreased T4 availability
at the tissue level at the time of follicle puncture. This increase
in TSH is in contrast with the generally observed decrease in
TSH during the first trimester of pregnancy (3–5). The pos-
sible significance of these findings lies in the recently de-
scribed association between maternal thyroid status and sub-
sequent neuropsychological development of the child (1, 2).
Pop et al. (1) found fT4 levels within the lowest 10th percentile
at 12 weeks gestation in apparently healthy women to be
associated with impaired psychomotor development at 10
months of age in their offspring. That these differences per-
sist into childhood has very recently been shown by Haddow
et al. (2), who provide evidence that children born from
mothers with hypothyroidism during the second trimester of
pregnancy have lower IQ scores and more school problems
at 7–9 yr of age than children born from mothers who were
euthyroid during pregnancy. These studies provide compel-
ling evidence that even relatively mild disturbances in ma-
ternal thyroid function can lead to persistent and clinically
relevant impairment in neuropsychological performance.
Animal, as well as human, studies have shown that due to
the inability of the fetal thyroid to produce thyroid hormone
during early pregnancy the maturing brain is totally depen-
dent on maternal supply of thyroid hormone (9–12), thus,
offering an explanation for the association between low ma-
ternal fT4 levels and impaired psychomotor development in
the offspring.
Ovarian hyperstimulation leads to hyperestrogenism,
which in turn leads to increased TBG levels (for review see
Ref. 3) and, therefore, to a decrease in fT4 (3). During early
pregnancy, some degree of thyroid stimulation by hCG ex-
ists; in some women this can give rise to gestational hyper-
thyroidism (3, 6). In molar pregnancy or chorionic carcinoma
severe hyperthyroidism may even be the presenting symp-
tom (6, 13, 14). Apparently, the hCG administration as ap-
plied during ovarian hyperstimulation is too short and/or
too low-dosed to counterbalance the opposing effect of in-
creased T4 binding.
It might be argued that thyroid function at baseline was
influenced by the phase of the menstrual cycle. However, it
has been shown previously that thyroid function is un-
changed during the follicular and luteal phases (5). Another
possible source of bias could be assay interference. However,
we found only negligible cross-reactivity. Moreover, during
ovarian hyperstimulation, PRL (a polypeptide hormone) in-
creased significantly and this change was near significantly
correlated with the rise in TSH (a glycoprotein hormone); r 5
0.22, P 5 0.09, indicating a pituitary source of TSH and not
assay cross-reactivity. Finally, we only measured TBG,
whereas albumin and transthyretin can bind T4 as well. How-
ever, during pregnancy the fraction of T4 bound by TBG
increases to more than 75%, as compared to two thirds in a
FIG. 2. TSH levels before and after ovarian stimulation.
FIG. 3. Change in E2 vs. change in TBG.
FIG. 4. Change in fT4 vs. change in TBG.
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nonpregnant state (3). In addition, concomitantly with the
rise in TBG, total T4 levels—measuring all bound T4—in-
creased as well.
There is strong evidence that sex steroids can modulate
Th1/Th2 cytokine balance in such a way that during preg-
nancy cell-mediated immune function and Th1 cytokine pro-
duction are suppressed and humoral immunity and Th2
cytokine production are enhanced (15, 16). The significant
decline in TPO titers argues against a role of thyroid auto-
immunity in the lowering of fT4 levels during controlled
ovarian hyperstimulation.
In several studies (17–22), no difference in the develop-
mental outcome in children conceived by conventional IVF
compared with non-IVF controls was found. However, in
none of these studies maternal fT4 levels in early gestation
were taken into consideration. When comparing children
conceived by ICSI (25% of our study subjects underwent
ICSI) with children conceived by conventional IVF, there is
an increased risk of developmental delay at 1 yr of age in
children conceived by ICSI (23). In our study, we found fT4
levels after ovarian hyperstimulation to be slightly higher in
women who subsequently underwent ICSI compared with
those who underwent conventional IVF.
In conclusion, we have found that ovarian hyperstimula-
tion leads to a lowering of fT4 levels with a concomitant rise
in TSH. These findings have potential implications for
women whose fT4 levels are already in the lower range of
normal before the start of ovarian hyperstimulation, espe-
cially if living in areas of iodine deficiency, with its relative
hypothyroxinemia during pregnancy (3, 4). We hypothesize
that if low maternal fT4 levels in early gestation lead to
impaired psychomotor development further lowering, albeit
only transiently, just before the period in which the devel-
oping brain is critically dependent on the maternal supply of
T4 may amplify this effect. These results indicate the need for
further research to determine whether the observed changes
in fT4 levels will, indeed, lead to delayed psychomotor de-
velopment in the offspring of women undergoing controlled
ovarian hyperstimulation.
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